search
Back to results

Heart Rate Informed Changes in Care for Non-Communicating Patients

Primary Purpose

Autism Spectrum Disorder, Intellectual Disability, Communication, Nonverbal

Status
Not yet recruiting
Phase
Not Applicable
Locations
Norway
Study Type
Interventional
Intervention
HR-informed change in routine
Delayed HR-informed specific change in routine
Sponsored by
University of Oslo
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Autism Spectrum Disorder focused on measuring Heart Rate, Autistic Disorder, Intellectual Disability, Social Interaction, Caregivers, Developmental Disabilities, Communication, Biomarkers, Pain

Eligibility Criteria

5 Years - 70 Years (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Between 5 and 70 years of age at the time of data collection Autism spectrum disorder as evaluated by clinical psychologist Communication difficulties Living at a care home with round-the-clock staff for at least five days a week; or attending one-to-one staffed school/day-care at least five days a week. Written informed consent is obtained from the subjects' legal representative. Exclusion Criteria: - Having any autoimmune disorder or any type of cancer with ongoing chemotherapy.

Sites / Locations

  • University of Oslo

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Intervention group

Control group

Arm Description

After 2 weeks mapping phase, patient-specific HR-informed intervention from week 3.

After 4 weeks mapping phase, patient-specific HR-informed intervention from week 5.

Outcomes

Primary Outcome Measures

Situations identified by 2 standard deviation increase in HR
The hypothesis is that a 2 standard deviation increase in HR can identify potentially painful care situations that require re-evaluation. Mean HR spike counts will be compared using a one-tailed paired sampled t-test to differentiate between suitable and unsuitable situations for care adjustments.

Secondary Outcome Measures

HRV (ms)
The hypothesis is that HR-informed changes in a patient-specific care procedures will potentially painful settings and thus reduce pain-related biomarkers of HRV as evaluated at the beginning and the end of the study period.
Serum concentrations of MCP-1, IL-1RA, IL-8, TGFβ1, and IL-17 (pg/ml)
The hypothesis is that HR-informed changes in a patient-specific care procedures will potentially painful settings and thus reduce pain-related blood biomarkers (MCP-1, IL-1RA, IL-8, TGFβ1, and IL-17) as evaluated at the beginning and the end of the study period.
Scores on quality of communication
The hypothesis is that HR as an aid in communication will increase caregivers' understanding of the patient as measured by changes in perceived understanding of the patient from the beginning to the end of the study period.

Full Information

First Posted
October 27, 2022
Last Updated
February 28, 2023
Sponsor
University of Oslo
search

1. Study Identification

Unique Protocol Identification Number
NCT05738278
Brief Title
Heart Rate Informed Changes in Care for Non-Communicating Patients
Official Title
Heart Rate Informed Changes in Care for Non-Communicating Patients: A Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
February 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
February 27, 2023 (Anticipated)
Primary Completion Date
December 30, 2025 (Anticipated)
Study Completion Date
December 30, 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Oslo

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The overarching aim is to generate knowledge to reduce incidence of pain in non-verbal patients' everyday life. The trial will 1) evaluate how HR can be used to identify potentially painful care procedures that should be re-evaluated in terms of the approach taken; 2) test the effect of heart rate (HR)-informed changes in potentially painful care procedures on biomarkers of pain, and 3) assess how six weeks of communication through HR affects the quality of communication between patient and caregiver.
Detailed Description
Detailed protocol to be published as journal article with reference to Clinicaltrials.gov-registration. Preprint available: https://osf.io/gan42

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Autism Spectrum Disorder, Intellectual Disability, Communication, Nonverbal
Keywords
Heart Rate, Autistic Disorder, Intellectual Disability, Social Interaction, Caregivers, Developmental Disabilities, Communication, Biomarkers, Pain

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Model Description
Thirty-eight non-verbal patients are recruited. HR is taken as a marker of acute pain. HR-Variability (HRV) and pain-related inflammatory cytokines (MCP-1, IL-1RA, IL-8, TGFβ1, and IL-17) are collected as measures of long-term pain. Caregivers will be asked to what degree they observe pain in their patients and how well they believe they understand their patient's expression. Collection is set to primary care institutions. HR is measured 8 hours/day over 2 weeks to identify increase of HR associated with potentially painful situations. Changes in procedures are in the form of change in 1) rigorousness of stretching, 2) preparations for casts, 3) lifting technique, or 4) personal hygiene procedure. To differentiate effects due to procedure-change from effects of covariates such as increased attentiveness when using HR; half the study group will start intervention in week 3 while the delayed group will continue data collection for another 2 weeks before introducing procedure changes.
Masking
Outcomes Assessor
Masking Description
Due to the objectives of the study, the identity of test and control treatments will not be known when analysing data. Access to the randomization code will be strictly controlled.
Allocation
Randomized
Enrollment
38 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Intervention group
Arm Type
Experimental
Arm Description
After 2 weeks mapping phase, patient-specific HR-informed intervention from week 3.
Arm Title
Control group
Arm Type
Active Comparator
Arm Description
After 4 weeks mapping phase, patient-specific HR-informed intervention from week 5.
Intervention Type
Behavioral
Intervention Name(s)
HR-informed change in routine
Intervention Description
The intervention is given for a situation occuring at least ten times and accompanied by an increase in HR at least 80% of the time, during the two-week registration period. Change in care (intervention) is introduced from week 3. The intervention is in one of four forms: changes in physiotherapy, e.g., less rigorous movement in the identified painful stretch, preparations for putting on corrective cast to stabilize joint and/or stretch spastic muscles, change in procedures for transportation/lifting, e.g., new technique or adaptations made to equipment, or revised personal hygiene procedure.
Intervention Type
Behavioral
Intervention Name(s)
Delayed HR-informed specific change in routine
Intervention Description
The intervention is given for a situation occuring at least twenty times and accompanied by an increase in HR at least 80% of the time, during the four-week registration period. Change in care (intervention) is introduced from week 5. The intervention is in one of four forms: changes in physiotherapy, e.g., less rigorous movement in the identified painful stretch, preparations for putting on corrective cast to stabilize joint and/or stretch spastic muscles, change in procedures for transportation/lifting, e.g., new technique or adaptations made to equipment, or revised personal hygiene procedure.
Primary Outcome Measure Information:
Title
Situations identified by 2 standard deviation increase in HR
Description
The hypothesis is that a 2 standard deviation increase in HR can identify potentially painful care situations that require re-evaluation. Mean HR spike counts will be compared using a one-tailed paired sampled t-test to differentiate between suitable and unsuitable situations for care adjustments.
Time Frame
11 weeks
Secondary Outcome Measure Information:
Title
HRV (ms)
Description
The hypothesis is that HR-informed changes in a patient-specific care procedures will potentially painful settings and thus reduce pain-related biomarkers of HRV as evaluated at the beginning and the end of the study period.
Time Frame
6 weeks
Title
Serum concentrations of MCP-1, IL-1RA, IL-8, TGFβ1, and IL-17 (pg/ml)
Description
The hypothesis is that HR-informed changes in a patient-specific care procedures will potentially painful settings and thus reduce pain-related blood biomarkers (MCP-1, IL-1RA, IL-8, TGFβ1, and IL-17) as evaluated at the beginning and the end of the study period.
Time Frame
6 weeks
Title
Scores on quality of communication
Description
The hypothesis is that HR as an aid in communication will increase caregivers' understanding of the patient as measured by changes in perceived understanding of the patient from the beginning to the end of the study period.
Time Frame
6 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
5 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Between 5 and 70 years of age at the time of data collection Autism spectrum disorder as evaluated by clinical psychologist Communication difficulties Living at a care home with round-the-clock staff for at least five days a week; or attending one-to-one staffed school/day-care at least five days a week. Written informed consent is obtained from the subjects' legal representative. Exclusion Criteria: - Having any autoimmune disorder or any type of cancer with ongoing chemotherapy.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Bjørnar Hassel, Professor
Phone
0047 98829754
Email
bjornar.hassel@medisin.uio.no
First Name & Middle Initial & Last Name or Official Title & Degree
Emilie SM Kildal
Phone
45481949
Email
eskildal@uio.no
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Bjørnar Hassel
Organizational Affiliation
University of Oslo
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Oslo
City
Oslo
ZIP/Postal Code
0450
Country
Norway

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
33742078
Citation
Kildal E, Stadskleiv K, Boysen ES, Oderud T, Dahl IL, Seeberg TM, Guldal S, Strisland F, Morland C, Hassel B. Increased heart rate functions as a signal of acute distress in non-communicating persons with intellectual disability. Sci Rep. 2021 Mar 19;11(1):6479. doi: 10.1038/s41598-021-86023-6.
Results Reference
background

Learn more about this trial

Heart Rate Informed Changes in Care for Non-Communicating Patients

We'll reach out to this number within 24 hrs